NCT06785324
- Conditions
- B Cell Acute Lymphoblastic Leukemia (B-ALL), B-ALL, Burkitt Lymphoma, +17 more
- Locations
-
- University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
3,646 public trials
848 recruiting studies
Lymphoma trial results
- Conditions
- Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT06700798
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
NCT07022964
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Beijing GoBroad Hospital Beijing, China
- Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, China
- Shanghai Liquan Hospital Shanghai, China
Recruiting
Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma
NCT07022223
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
- Dongyang People's Hospital Dongyang, China
- Affiliated Hangzhou First People's Hospital Hangzhou, China
- Zhejiang cancer Hospital Hangzhou, China
NCT05253495
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +9 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- University of Flordia Gainsville, Florida, United States
- New York Medical College Vallhala, New York, United States
Recruiting
Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma
NCT06830031
- Conditions
- DLBCL, Nos Genetic Subtypes, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B-cell-lymphoma, +22 more
- Locations
-
- Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, China
Recruiting
JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
NCT06940960
- Conditions
- B Acute Lymphoblastic Leukemia, B-Non Hodgkin Lymphoma, Burkitt Lymphoma, +16 more
- Locations
-
- Affiliated Hospital of Guangdong Medical University Guangzhou, Guangdong, China
NCT05541341
- Conditions
- Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Follicular Lymphoma, +16 more
- Locations
-
- Novartis Investigative Site Minas Gerais, Belo Horizonte, Brazil
- Novartis Investigative Site Salvador, Estado de Bahia, Brazil
- Novartis Investigative Site Curitiba, Paraná, Brazil
- Novartis Investigative Site São Paulo, Brazil
Recruiting
Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
NCT06793410
- Conditions
- Acute Myeloid Leukaemia, Bone Marrow Diseases, Communicable Diseases, +32 more
- Locations
-
- Skåne's University Hospital Lund, Region Skåne, Sweden
- Karolinska University Hospital Stockholm, Region Stockholm, Sweden
- Uppsala University Hospital Uppsala, Region Uppsala, Sweden
- Linköping University Hospital Linköping, Region Östergötaland, Sweden